Company Profiles

driven by the PitchBook Platform

Arcus Biosciences

Description

Developer of innovative cancer immunotherapies designed to treat cancer. The company's innovative cancer immunotherapies targets one or more therapeutic nodes and discover drugs that block tumors' ability to highjack the immune system, enabling patients to recover cancer.

2015

Founded

PRIVATE

Status

1-10

Employees

Series B

Latest Deal Type

$70M

Latest Deal Amount

$120M

Total Amount Raised

Description

Developer of innovative cancer immunotherapies designed to treat cancer. The company's innovative cancer immunotherapies targets one or more therapeutic nodes and discover drugs that block tumors' ability to highjack the immune system, enabling patients to recover cancer.

Website:

www.arcusbio.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

3928 Point Eden Way Hayward, CA 94545United States +1 (510) 694-6200
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Arcus Biosciences's full profile, request a free trial.

Arcus Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Arcus Biosciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Arcus Biosciences Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
CelgeneCorporationMinority000 0000000 0000
Droia Oncology VenturesVenture CapitalMinority000 0000000 0000
GVCorporate Venture CapitalMinority000 0000000 0000
Invus GroupPE/BuyoutMinority000 0000000 0000
Karl HandelsmanAngel (individual)Minority000 0000000 0000
Celgene Corporation
Droia Oncology Ventures Venture Capital
GV Corporate Venture Capital
Invus Group PE/Buyout
Karl Handelsman Angel (individual)

Arcus Biosciences Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Terry Rosen Ph.DCo-Founder and Chief Executive Officer
Juan Jaen Ph.DCo-Founder, Chief Scientific Officer & President
Jay Powers Ph.DVice President, Drug Discovery
Ulrike SchindlerVice President of Biology
Nigel Walker Ph.DVice President, Protein Science
Terry Rosen Ph.D Co-Founder and Chief Executive Officer
Juan Jaen Ph.D Co-Founder, Chief Scientific Officer & President
Jay Powers Ph.D Vice President, Drug Discovery
Ulrike Schindler Vice President of Biology
Nigel Walker Ph.D Vice President, Protein Science
Request full access to PitchBook